SVB Wealth LLC Buys 15,611 Shares of Centene Corporation $CNC

SVB Wealth LLC increased its stake in shares of Centene Corporation (NYSE:CNCFree Report) by 58.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,395 shares of the company’s stock after acquiring an additional 15,611 shares during the quarter. SVB Wealth LLC’s holdings in Centene were worth $1,745,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CNC. AQR Capital Management LLC lifted its stake in shares of Centene by 76.6% in the third quarter. AQR Capital Management LLC now owns 14,654,834 shares of the company’s stock valued at $522,885,000 after buying an additional 6,356,152 shares in the last quarter. Deerfield Management Company L.P. lifted its stake in shares of Centene by 184.0% in the third quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock valued at $322,761,000 after buying an additional 5,860,630 shares in the last quarter. 8 Knots Management LLC bought a new position in shares of Centene in the third quarter valued at $186,662,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Centene by 32.0% in the third quarter. Arrowstreet Capital Limited Partnership now owns 8,716,056 shares of the company’s stock valued at $310,989,000 after buying an additional 2,111,674 shares in the last quarter. Finally, Long Focus Capital Management LLC lifted its stake in shares of Centene by 705.4% in the third quarter. Long Focus Capital Management LLC now owns 2,299,000 shares of the company’s stock valued at $82,028,000 after buying an additional 2,013,560 shares in the last quarter. 93.63% of the stock is owned by institutional investors.

Centene Stock Performance

Shares of CNC stock opened at $56.35 on Tuesday. The firm has a 50-day moving average of $40.13 and a 200-day moving average of $40.17. The company has a market cap of $27.82 billion, a P/E ratio of -4.29, a P/E/G ratio of 1.08 and a beta of 1.06. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.12 and a quick ratio of 1.12. Centene Corporation has a one year low of $25.08 and a one year high of $64.15.

Centene (NYSE:CNCGet Free Report) last announced its earnings results on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, beating the consensus estimate of $2.23 by $1.14. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The company had revenue of $49.94 billion during the quarter, compared to the consensus estimate of $47.53 billion. During the same quarter in the prior year, the company posted $2.90 earnings per share. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. Equities research analysts forecast that Centene Corporation will post 3.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CNC. Oppenheimer reaffirmed an “outperform” rating and issued a $58.00 price objective (up from $45.00) on shares of Centene in a research note on Wednesday, April 29th. Bank of America raised shares of Centene from an “underperform” rating to a “buy” rating and raised their price objective for the company from $34.00 to $60.00 in a research note on Wednesday, April 29th. Sanford C. Bernstein increased their target price on shares of Centene from $48.00 to $68.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. TD Cowen reiterated a “hold” rating and issued a $47.00 target price (up from $38.00) on shares of Centene in a report on Monday, May 4th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a report on Monday, April 20th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $53.82.

Read Our Latest Report on CNC

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Stories

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.